TIMELESS Trial Shows Promise in Expanding Time Window for Stroke Treatment

Recent developments in stroke care have shown promising results in expanding the time window for thrombolysis, a critical treatment for eligible stroke patients. The TIMELESS trial, led by Gregory W. Albers, MD, has demonstrated the safety of tenecteplase in later-window poststroke patients, opening new possibilities for treatment. The findings from the TIMELESS trial have sparked discussions within the medical community about the potential implications for stroke care. While the trial did not achieve statistical significance in its primary outcome, the safety demonstrated in treating later-window poststroke patients with tenecteplase is a notable development.